— Know what they know.
Not Investment Advice

ACXP NASDAQ

Acurx Pharmaceuticals, Inc.
1W: -6.6% 1M: -11.2% 3M: -19.6% YTD: -54.0% 1Y: -72.4% 3Y: -95.5% 5Y: -98.5%
$1.27
+0.01 (+0.79%)
 
Weekly Expected Move ±3.8%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 21 · $5.5M mcap · 4M float · 2.89% daily turnover · Short 50% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-05-08
Earliest Filing
2025-05-08
Latest Filing
investor: 1

Counterparties (Filed by ACXP)

1 relationships

Companies named in ACXP's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Lincoln Park Capital Fund, LLC — investor Committed to purchase up to $12.0 million in shares of common stock and entered into a registration rights agreement. 2025-05-08 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-04-16 Material Agreement; Unregistered Equity Sales; Other Events; Exhibits Agreement View
2026-03-09 Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh View
2025-09-22 Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits View
2025-09-19 Submission of Matters to a Vote of Security Holders View
2025-07-31 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-07-17 Submission of Matters to a Vote of Security Holders View
2025-06-20 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2025-05-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-05-08 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2025-03-28 Notice of Delisting or Transfer View
2025-03-18 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-10 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2025-02-26 Notice of Delisting or Transfer View
2025-01-07 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2024-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-06-17 Submission of Matters to a Vote of Security Holders View
2024-05-15 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2023-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2023-11-03 Other Events; Financial Statements and Exhibits View
2023-10-02 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms